{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:41:21Z","timestamp":1792716081918,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["15400"],"award-info":[{"award-number":["15400"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15347-7","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T01:47:14Z","timestamp":1764208034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["[18F]F-FAPI PET\/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study)"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7057-0274","authenticated-orcid":false,"given":"Lianne","family":"Triemstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6902-2182","authenticated-orcid":false,"given":"Sarah W. J. M.","family":"Spruijt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5762-6766","authenticated-orcid":false,"given":"Dennis","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-2258","authenticated-orcid":false,"given":"Erik","family":"Vegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-4778","authenticated-orcid":false,"given":"Wilma E.","family":"Mesker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-9325","authenticated-orcid":false,"given":"Lukas J. A. C.","family":"Hawinkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9654","authenticated-orcid":false,"given":"Sopany","family":"Saing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-8656","authenticated-orcid":false,"given":"Marije","family":"Slingerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4910-4655","authenticated-orcid":false,"given":"Vera","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-4406","authenticated-orcid":false,"given":"Stijn A. L. P.","family":"Crobach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-0259","authenticated-orcid":false,"given":"Jelle J.","family":"Goeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4892-3109","authenticated-orcid":false,"given":"Martin","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-8270","authenticated-orcid":false,"given":"Petra","family":"Dibbets-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-1416","authenticated-orcid":false,"given":"Roel J.","family":"Bennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8689-3134","authenticated-orcid":false,"given":"Mark I.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7338-2818","authenticated-orcid":false,"given":"Marc J.","family":"van Det","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2900-2942","authenticated-orcid":false,"given":"Boudewijn J.","family":"van Etten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-8556","authenticated-orcid":false,"given":"Henk H.","family":"Hartgrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-261X","authenticated-orcid":false,"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-9790","authenticated-orcid":false,"given":"Marnix G. E. H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda M.","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-1520","authenticated-orcid":false,"given":"Misha D. P.","family":"Luyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-5499","authenticated-orcid":false,"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5242-2340","authenticated-orcid":false,"given":"Emilia C.","family":"Owers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-7078","authenticated-orcid":false,"given":"Wim J. G.","family":"Oyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-6388","authenticated-orcid":false,"given":"Johanna W.","family":"van Sandick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Schreurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-7798","authenticated-orcid":false,"given":"Wobbe O.","family":"de Steur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-0049","authenticated-orcid":false,"given":"Jan H. M. B.","family":"Stoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo E.","family":"Weijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-3697","authenticated-orcid":false,"given":"Bas P. L.","family":"Wijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P. L.","family":"Witteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6584-1677","authenticated-orcid":false,"given":"Jelle P.","family":"Ruurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1817-2743","authenticated-orcid":false,"given":"Lioe-Fee","family":"de Geus-Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PLASTIC-3 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"3","key":"15347_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"15347_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","volume":"11","author":"I Songun","year":"2010","unstructured":"Songun I, Putter H, Kranenbarg EMK, Sasako M, van de Velde CJH. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439\u201349.","journal-title":"Lancet Oncol"},{"issue":"10184","key":"15347_CR3","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357.","journal-title":"Lancet"},{"key":"15347_CR4","doi-asserted-by":"crossref","unstructured":"Cunningham D, Allum WH, Stenning SP. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11\u201320.","DOI":"10.1056\/NEJMoa055531"},{"issue":"1","key":"15347_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa073149","volume":"358","author":"D Cunningham","year":"2008","unstructured":"Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358(1):36\u201346.","journal-title":"N Engl J Med"},{"key":"15347_CR6","unstructured":"Oncoline. Landelijke werkgroep gastro-intestinale tumoren versie: 2.2. 2017. 2017. Available from: https:\/\/www.oncoline.nl\/maagcarcinoom. Cited 2020 Aug 31."},{"issue":"12","key":"15347_CR7","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1001\/jamasurg.2021.5340","volume":"156","author":"EC Gertsen","year":"2021","unstructured":"Gertsen EC, Brenkman HJF, Van Hillegersberg R, Van Sandick JW, Van Berge Henegouwen MI, Gisbertz SS, et al. 18F-fludeoxyglucose-positron emission tomography\/computed tomography and laparoscopy for staging of locally advanced gastric cancer: a multicenter prospective Dutch cohort study (PLASTIC). JAMA Surg. 2021;156(12):E1-9.","journal-title":"JAMA Surg"},{"issue":"9","key":"15347_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59(9):1415\u201322.","journal-title":"J Nucl Med"},{"issue":"8","key":"15347_CR9","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"15347_CR10","doi-asserted-by":"crossref","unstructured":"G\u00fcndo\u011fan C, K\u00f6mek H, Can C, Yildirim \u00d6A, Kaplan \u0130, Erdur E, et al. Comparison of 18F-FDG PET\/CT and 68Ga-FAPI-04 PET\/CT in the staging and restaging of gastric adenocarcinoma. Nucl Med Commun. 2022;43(1):64\u201372.","DOI":"10.1097\/MNM.0000000000001489"},{"issue":"2","key":"15347_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s00259-021-05441-w","volume":"49","author":"D Jiang","year":"2022","unstructured":"Jiang D, Chen X, You Z, Wang H, Zhang X, Li X, et al. Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study. Eur J Nucl Med Mol Imaging. 2022;49(2):732\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"15347_CR12","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","volume":"49","author":"R Lin","year":"2022","unstructured":"Lin R, Lin Z, Chen Z, Zheng S, Zhang J, Zang J, et al. [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2022;49(8):2960\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"15347_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00259-021-05494-x","volume":"49","author":"J Kuten","year":"2022","unstructured":"Kuten J, Levine C, Shamni O, Pelles S, Wolf I, Lahat G, et al. Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma. Eur J Nucl Med Mol Imaging. 2022;49(2):743\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"15347_CR14","first-page":"12","volume":"1","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wang W, Xu T, Ding H, Li Y, Liu H, et al. Comparison of diagnostic efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET\/CT for staging and restaging of gastric cancer. Front Oncol. 2022;1:12.","journal-title":"Front Oncol"},{"key":"15347_CR15","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1007\/s00330-022-09321-1","volume":"33","author":"Y Miao","year":"2023","unstructured":"Miao Y, Feng R, Guo R, Huang X, Hai W, Li J, et al. Utility of [68Ga]FAPI-04 and [18 F]FDG dual-tracer PET\/CT in the initial evaluation of gastric cancer. Eur Radiol. 2023;33:4355\u201366.","journal-title":"Eur Radiol"},{"key":"15347_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/jso.24517","volume":"115","author":"A Russo","year":"2017","unstructured":"Russo A, Li P, Strong VE. Differences in the multimodal treatment of gastric cancer: east versus west. J Surg Oncol. 2017;115:603\u201314.","journal-title":"J Surg Oncol"},{"issue":"8","key":"15347_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.clon.2019.05.012","volume":"31","author":"WL Chan","year":"2019","unstructured":"Chan WL, Lam KO, Lee VHF, Davidson M, So TH, Li JS, et al. Gastric cancer \u2013 from aetiology to management: differences between the east and the west. Clin Oncol. 2019;31(8):570\u20137.","journal-title":"Clin Oncol"},{"issue":"11","key":"15347_CR18","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gutjnl-2014-308252","volume":"64","author":"SJ Lin","year":"2015","unstructured":"Lin SJ, Gagnon-Bartsch JA, Tan IB, Earle S, Ruff L, Pettinger K, et al. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut. 2015;64(11):1721\u201331.","journal-title":"Gut"},{"key":"15347_CR19","unstructured":"American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. 2017."},{"key":"15347_CR20","unstructured":"Federatie Medisch Specialisten. Richtlijn maagcarcinoom. 2023."},{"issue":"2","key":"15347_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/0284186X.2017.1346381","volume":"57","author":"R Coebergh van den Braak","year":"2017","unstructured":"Coebergh van den Braak R, van Rijssen L, van Kleef J, Vink G, Berbee M, van Berge Henegouwen M, et al. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative. Acta Oncol. 2017;57(2):195\u2013202.","journal-title":"Acta Oncol"},{"key":"15347_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00259-018-4153-6","volume":"46","author":"A Rahmim","year":"2019","unstructured":"Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, et al. Dynamic whole-body PET imaging: principles, potentials and applications. Eur J Nucl Med Mol Imaging. 2019;46:501\u201318 (Springer Berlin Heidelberg).","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"15347_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.120.245084","volume":"62","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Adeberg S, Syed M, Lindner T, Jim\u00e9nez-Franco LD, Mavriopoulou E, et al. FAPI-74 PET\/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients. J Nucl Med. 2021;62(2):201\u20137.","journal-title":"J Nucl Med"},{"issue":"8","key":"15347_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2967\/jnumed.123.265486","volume":"64","author":"T Watabe","year":"2023","unstructured":"Watabe T, Naka S, Tatsumi M, Kamiya T, Kimura T, Shintani Y, et al. Initial evaluation of [18F]FAPI-74 PET for various histopathologically confirmed cancers and benign lesions. J Nucl Med. 2023;64(8):1225\u201331.","journal-title":"J Nucl Med"},{"key":"15347_CR25","unstructured":"Slart RHJA, Kool W, Zwezerijnen GJC, van den Hoven AF. Acquisitie protocol NVNG FAPI werkgroep [Internet]. NVNG; 2023 Jun 21 [cited 2025 Sept 26]. Available from: https:\/\/www.fapiwerkgroep.nl\/docs\/FAPI%20PET-CT%20acquisitie%20protocol_NVNG%20FAPI%20werkgroep_v001_21-06-2023.pdf\u00a0"},{"key":"15347_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108278","author":"K van der Sluis","year":"2024","unstructured":"van der Sluis K, Guchelaar NAD, Triemstra L, Mathijssen RHJ, Ruurda JP, Wijnhoven BPL, et al. Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus towards a standardized protocol. Eur J Surg Oncol. 2024 Jun;50(6):108278. https:\/\/doi.org\/10.1016\/j.ejso.2024.108278.","journal-title":"Eur J Surg Oncol"},{"key":"15347_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"issue":"1","key":"15347_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10120-017-0749-y","volume":"21","author":"S Jamel","year":"2018","unstructured":"Jamel S, Markar SR, Malietzis G, Acharya A, Athanasiou T, Hanna GB. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis. Gastric Cancer. 2018;21(1):10\u20138.","journal-title":"Gastric Cancer"},{"issue":"22","key":"15347_CR29","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1002\/cncr.27550","volume":"118","author":"E Smyth","year":"2012","unstructured":"Smyth E, Sch\u00f6der H, Strong VE, Capanu M, Kelsen DP, Coit DG, et al. A prospective evaluation of the utility of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012;118(22):5481\u20138.","journal-title":"Cancer"},{"issue":"3","key":"15347_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"5","key":"15347_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"N Aaronson","year":"1993","unstructured":"Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"15347_CR32","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"key":"15347_CR33","unstructured":"iMTA Productivity and Health Research Group. Manual iMTA Productivity Cost Questionnaire (iPCQ). Rotterdam: iMTA, Erasmus University Rotterdam; 2018."},{"key":"15347_CR34","unstructured":"iMTA Productivity and Health Research Group. Manual iMTA Medical Cost Questionnaire (iMCQ). Rotterdam: iMTA, Erasmus University Rotterdam; 2018."},{"issue":"4","key":"15347_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","volume":"19","author":"M Versteegh","year":"2016","unstructured":"Versteegh M, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343\u201352.","journal-title":"Value Health"},{"key":"15347_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112874","author":"LCE Pullen","year":"2023","unstructured":"Pullen LCE, Noortman WA, Triemstra L, de Jongh C, Rademaker FJ, Spijkerman R, et al. Prognostic value of [18F]FDG PET radiomics to detect peritoneal and distant metastases in locally advanced gastric cancer\u2014a side study of the prospective multicentre PLASTIC study. Cancers (Basel). 2023 May 23;15(11):2874. https:\/\/doi.org\/10.3390\/cancers15112874.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"15347_CR37","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X","volume":"92","author":"T Kawamura","year":"2001","unstructured":"Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. 2001;92(3):634\u201341.","journal-title":"Cancer"},{"key":"15347_CR38","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, et al. Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48:1944\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15347-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:30:38Z","timestamp":1769513438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15347"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15347-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Research Ethics Committee (MREC, Dutch: METC) Leiden-The Hague-Delft (reference number: P25.012) on May 5th 2025. As this study does allocate patients to study interventions other than usual care, as recommended by the Dutch guidelines, this study does fall within the Medical Research Involving Human Subjects Act (WMO). Written informed consent will be obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MIBH is consultant for Intuitive, Johnson and Johnson, Medtronic, Stryker and BBraun (all fees paid to institution). LJACH received consultant fees and is member scientific advisory board of InnoSer Biosciences (not related). MGEHL is consultant and research support for Terumo, Boston Scientific, consultant for OncoSil, Becton and Dickinson and Novartis. MDPL received grants from Medtronic and Galvani for research. All other authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}